Updated Efficacy/Safety Data From the Phase 2 NP28761 Study of Alectinib in ALK plus NSCLC

被引：0

作者：

Shaw, Alice ^{[1
]}

West, Howard ^{[2
]}

Socinski, Mark A. ^{[3
]}

Ou, Ignatius ^{[4
]}

Gandhi, Leena ^{[5
]}

Gadgeel, Shirish ^{[6
]}

Belani, Chandra P. ^{[7
]}

Shirai, Keisuke ^{[8
]}

Bazhenova, Lyudmila ^{[9
]}

Santos, Edgardo ^{[10
]}

Riely, Gregory J. ^{[11
]}

Chiappori, Alberto ^{[12
]}

Cetnar, Jeremy ^{[13
]}

Mekhail, Tarek ^{[14
]}

Chao, Bo ^{[15
]}

Borghaei, Hossein ^{[16
]}

Gold, Kathryn A. ^{[17
]}

Johannsdottir, Hrefna ^{[18
]}

Ruf, Thorsten ^{[18
]}

Boisserie, Frederic ^{[18
]}

Henschel, Volkmar ^{[18
]}

Zeaiter, Ali ^{[18
]}

Camidge, Ross ^{[19
]}

机构：

[1] Massachusetts Gen Hosp, Boston, MA 02114 USA

[2] Swedish Canc Inst, Seattle, WA USA

[3] Univ Pittsburgh, Pittsburgh, PA USA

[4] Univ Calif Irvine, Orange, CA 92668 USA

[5] Dana Farber Canc Inst, Boston, MA 02115 USA

[6] Wayne State Univ, Detroit, MI USA

[7] Penn State Hershey Canc Inst, Hershey, PA USA

[8] Med Univ S Carolina, Charleston, SC 29425 USA

[9] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA

[10] Florida Atlantic Univ, Lynn Canc Inst, Oncol, Boca Raton, FL 33431 USA

[11] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[12] H Lee Moffitt Canc Ctr & Res Inst Inc, Thorac Oncol, Tampa, FL USA

[13] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[14] Florida Hosp Canc Insititute, Orlando, FL USA

[15] Ohio State Univ, Internal Med, Columbus, OH 43210 USA

[16] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA

[17] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[18] F Hoffmann La Roche Ltd, Basel, Switzerland

[19] Univ Colorado, Med, Denver, CO 80202 USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期

关键词：

Alectinib; ALK; NSCLC;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ORAL33.03

引用

页码：S237 / S238

页数：2